Jove
Visualize
Contact Us

Related Experiment Videos

Acute ST-elevation myocardial infarction.

P R Sinnaeve1

  • 1Department of Cardiology, Gasthuisberg University Hospital, University of Leuven, Leuven, Belgium. peter.sinnaeve@uz.kuleuven.ac.be

Acta Clinica Belgica
|January 24, 2007
PubMed
Summary

Acute ST-elevation myocardial infarction (STEMI) is a major killer, often stemming from undiagnosed coronary artery disease. Prompt treatment and guideline adherence are crucial for better outcomes and managing heart failure post-infarction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A contemporary look at pericardiocentesis.

Trends in cardiovascular medicine·2018
Same author

Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation.

Journal of internal medicine·2011
Same author

Will oral antithrombin agents replace warfarin?

Heart (British Cardiac Society)·2004
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • Acute ST-elevation myocardial infarction (STEMI) is a primary cause of mortality in industrialized nations.
  • Many STEMI cases represent the initial manifestation of underlying atherosclerotic coronary artery disease.
  • Delayed medical attention due to symptom misinterpretation contributes to poorer patient outcomes.

Purpose of the Study:

  • To review the established paradigm of early, complete, and sustained infarct-related artery patency in STEMI management.
  • To discuss the impact of aggressive therapies like fibrinolysis and primary PCI on STEMI patient outcomes.
  • To highlight challenges in guideline adherence and the growing prevalence of chronic heart failure post-myocardial infarction.

Main Methods:

  • Literature review of studies on STEMI management and outcomes.
  • Analysis of therapeutic strategies including fibrinolysis and primary percutaneous coronary intervention (PCI).
  • Examination of factors influencing patient outcomes, including treatment adherence and the development of chronic heart failure.

Main Results:

  • Early, complete, and sustained infarct-related artery patency is a proven beneficial strategy in STEMI.
  • Aggressive reperfusion therapies (fibrinolysis, primary PCI) have improved outcomes for many STEMI patients.
  • Suboptimal adherence to treatment guidelines and the increasing incidence of chronic heart failure remain significant concerns.

Conclusions:

  • Despite advances, suboptimal guideline adherence negatively impacts STEMI patient outcomes.
  • Effective management of STEMI requires timely revascularization and consistent adherence to evidence-based treatment protocols.
  • The growing population of patients with chronic heart failure post-myocardial infarction necessitates ongoing research and improved care strategies.

Related Experiment Videos